Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Readily Diagnostics in conjunction with capital raising
Mandate

Vinge advises Readily Diagnostics in conjunction with capital raising

October 30, 2024

Readily Diagnostics, an Uppsala-based company specialising in the development of rapid and accurate diagnostic tests, has completed a capital raising of EUR 1.6 million.

Beijerstiftelsen and Länsförsäkringar Uppsala, inter alia, have been added as new shareholders and several existing shareholders such as Almi Invest, Ulf Landegren and Uppsala Universitet Invest have also participated.

Vinge, through Johan Winnerblad, has advised Readily.

Related

Vinge advises Main Capital and Björn Lundén in connection with the acquisition of Aprello

 Vinge has advised Björn Lundén, a provider of accounting and financial administration software, in connection with the acquisition of Aprello AB (“Aprello”). The strategic acquisition complements Björn Lundén’s growth strategy in the European financial administration software market.
January 30, 2025

Vinge advises ABGSC in connection with EQL Pharma’s inaugural bond issuance

 Vinge has advised ABG Sundal Collier in connection with EQL Pharma AB (publ)’s ( “EQL”) inaugural issuance of SEK 350,000,000 senior secured bonds within a framework of up to SEK 700,000.
January 24, 2025

Vinge advises the majority shareholders Altor, Telia Company, Time For Growth and Zenith VC in the divestment of shares in Marshall Group

 Vinge advises the majority shareholders Altor, Telia Company, Time For Growth and Zenith VC in connection with the divestment of shares in Marshall Group AB (publ) (”Marshall Group”) to HongShan Group, formerly known as Sequoia China. The Marshall Family will continue as owner in the Marshall Group.
January 24, 2025